Clinical Trials
3
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)Tocilizumab in Schizophrenia
Phase 1
Recruiting
- Conditions
- Psychotic DisordersSchizophrenia
- Interventions
- Drug: Normal saline
- First Posted Date
- 2016-08-22
- Last Posted Date
- 2023-07-21
- Lead Sponsor
- Brian Miller
- Target Recruit Count
- 20
- Registration Number
- NCT02874573
- Locations
- 🇺🇸
Augusta University, Augusta, Georgia, United States
Siltuximab in Schizophrenia
Phase 1
Recruiting
- Conditions
- SchizophreniaPsychotic Disorders
- Interventions
- Drug: normal saline
- First Posted Date
- 2016-06-13
- Last Posted Date
- 2023-07-21
- Lead Sponsor
- Brian Miller
- Target Recruit Count
- 30
- Registration Number
- NCT02796859
- Locations
- 🇺🇸
Augusta University, Augusta, Georgia, United States
An Open-Label Trial of Tocilizumab in Schizophrenia
- First Posted Date
- 2012-10-02
- Last Posted Date
- 2021-07-29
- Lead Sponsor
- Brian Miller
- Target Recruit Count
- 8
- Registration Number
- NCT01696929
- Locations
- 🇺🇸
Georgia Health Sciences University, Augusta, Georgia, United States
News
No news found